UBS AM’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.81M | Buy |
470,432
+135,476
| +40% | +$1.1M | ﹤0.01% | 1831 |
|
|
2025
Q1 | $2.81M | Buy |
334,956
+16,536
| +5% | +$139K | ﹤0.01% | 1837 |
|
|
2024
Q4 | $2.52M | Buy |
318,420
+99,866
| +46% | +$791K | ﹤0.01% | 1934 |
|
|
2024
Q3 | $1.82M | Sell |
218,554
-46,170
| -17% | -$384K | ﹤0.01% | 2083 |
|
|
2024
Q2 | $1.68M | Buy |
264,724
+228,295
| +627% | +$1.45M | ﹤0.01% | 2092 |
|
|
2024
Q1 | $221K | Buy |
+36,429
| New | +$221K | ﹤0.01% | 2445 |
|
|
2023
Q3 | – | Sell |
-84,912
| Closed | -$118K | – | 2593 |
|
|
2023
Q2 | $118K | Hold |
84,912
| – | – | ﹤0.01% | 2631 |
|
|
2023
Q1 | $118K | Hold |
84,912
| – | – | ﹤0.01% | 2631 |
|
|
2022
Q4 | $169K | Hold |
84,912
| – | – | ﹤0.01% | 2463 |
|
|
2022
Q3 | $172K | Sell |
84,912
-14,073
| -14% | -$28.4K | ﹤0.01% | 2633 |
|
|
2022
Q2 | $315K | Hold |
98,985
| – | – | ﹤0.01% | 2470 |
|
|
2022
Q1 | $413K | Hold |
98,985
| – | – | ﹤0.01% | 2524 |
|
|
2021
Q4 | $474K | Hold |
98,985
| – | – | ﹤0.01% | 2580 |
|
|
2021
Q3 | $529K | Hold |
98,985
| – | – | ﹤0.01% | 2478 |
|
|
2021
Q2 | $507K | Buy |
98,985
+12,036
| +14% | +$61.6K | ﹤0.01% | 2530 |
|
|
2021
Q1 | $585K | Sell |
86,949
-2,656
| -3% | -$17.9K | ﹤0.01% | 2331 |
|
|
2020
Q4 | $409K | Sell |
89,605
-24,909
| -22% | -$114K | ﹤0.01% | 2353 |
|
|
2020
Q3 | $444K | Hold |
114,514
| – | – | ﹤0.01% | 2191 |
|
|
2020
Q2 | $545K | Sell |
114,514
-2,214
| -2% | -$10.5K | ﹤0.01% | 2089 |
|
|
2020
Q1 | $406K | Buy |
116,728
+31,191
| +36% | +$109K | ﹤0.01% | 2051 |
|
|
2019
Q4 | $412K | Sell |
85,537
-20,939
| -20% | -$101K | ﹤0.01% | 2300 |
|
|
2019
Q3 | $309K | Buy |
106,476
+15,769
| +17% | +$45.7K | ﹤0.01% | 2450 |
|
|
2019
Q2 | $650K | Buy |
90,707
+33,033
| +57% | +$237K | ﹤0.01% | 2086 |
|
|
2019
Q1 | $817K | Buy |
57,674
+20,827
| +57% | +$295K | ﹤0.01% | 1898 |
|
|
2018
Q4 | $499K | Sell |
36,847
-13,514
| -27% | -$183K | ﹤0.01% | 1997 |
|
|
2018
Q3 | $1.12M | Buy |
50,361
+20,163
| +67% | +$447K | ﹤0.01% | 1770 |
|
|
2018
Q2 | $496K | Buy |
+30,198
| New | +$496K | ﹤0.01% | 2099 |
|